Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 3/2007

01-01-2007 | Letter to the Editor

Acute renal failure in a patient with familial Mediterranean fever

Authors: Z. Birsin Özçakar, Selçuk Yüksel, Arzu Ensari, Mesiha Ekim, Fatoş Yalçınkaya

Published in: Rheumatology International | Issue 3/2007

Login to get access

Excerpt

Familial Mediterranean fever (FMF) is an autosomal recessive disease, characterized by recurrent, self-limited attacks of fever with serositis involving the peritoneum, pleura and joints. The disease is caused by mutations in the FMF gene (MEFV) located on chromosome 16. Renal involvement is one of the most important features of the disease [1‐3]. …
Literature
1.
Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253PubMedCrossRef
2.
The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17 25–31CrossRef
3.
Majeed HA, Rawashdeh M, El-Shanti H, Quabain H, Khuribulos N, Shahın HM (1999) Familial Mediterranean fever in children: the expanded clinical profile. QJ Med 92:309–318
4.
Yalçınkaya F, Tümer N (1999) Glomerular lesions other than amyloidosis in patients with familial Mediterranean fever. Nephrol Dial Transplant 14:21–23PubMedCrossRef
5.
Tekin M, Yalçınkaya F, Tümer N, Çakar N, Koçak H, Özkaya N, Gençgönül H (1999) Familial Mediterranean fever-renal involvement by diseases other than amyloid. Nephrol Dial Transplant 14:475–479PubMedCrossRef
6.
Stefanidis I, Bohm R, Hagel J, Maurin N (1992) Toxic myopathy with kidney failure as a colchicine side effect in familial Mediterranean fever. Dtsch Med Wochenschr 117:1237–1240PubMedCrossRef
Metadata
Title
Acute renal failure in a patient with familial Mediterranean fever
Authors
Z. Birsin Özçakar
Selçuk Yüksel
Arzu Ensari
Mesiha Ekim
Fatoş Yalçınkaya
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0205-5

Other articles of this Issue 3/2007

Rheumatology International 3/2007 Go to the issue

Case Report

Primary antiphospholipid nephropathy beginning during pregnancy

Case Report

Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still’s disease

Original Article

Pamidronate and osteoporosis prevention in liver transplant recipients

Original Article

Arthritis as a presenting symptom in a hypogammaglobulinemic patient with thymectomy

Case Report

Rhodococcus equi infection during treatment of a C-ANCA positive vasculitis: a case report

Case Report

Full-house nephropathy in a patient with negative serology for lupus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits